Exploring Heparan Sulfate Proteoglycans As Mediators of Human Mesenchymal Stem Cell Neurogenesis

Sofia I. Petersen,Rachel K. Okolicsanyi,Larisa M. Haupt

Cellular and Molecular Neurobiology（2024）

Queensland University of Technology (QUT)

Cited 0|Views10

Abstract

Alzheimer’s disease (AD) and traumatic brain injury (TBI) are major public health issues worldwide, with over 38 million people living with AD and approximately 48 million people (27–69 million) experiencing TBI annually. Neurodegenerative conditions are characterised by the accumulation of neurotoxic amyloid beta (Aβ) and microtubule-associated protein Tau (Tau) with current treatments focused on managing symptoms rather than addressing the underlying cause. Heparan sulfate proteoglycans (HSPGs) are a diverse family of macromolecules that interact with various proteins and ligands and promote neurogenesis, a process where new neural cells are formed from stem cells. The syndecan (SDC) and glypican (GPC) HSPGs have been implicated in AD pathogenesis, acting as drivers of disease, as well as potential therapeutic targets. Human mesenchymal stem cells (hMSCs) provide an attractive therapeutic option for studying and potentially treating neurodegenerative diseases due to their relative ease of isolation and subsequent extensive in vitro expansive potential. Understanding how HSPGs regulate protein aggregation, a key feature of neurodegenerative disorders, is essential to unravelling the underlying disease processes of AD and TBI, as well as any link between these two neurological disorders. Further research may validate HSPG, specifically SDCs or GPCs, use as neurodegenerative disease targets, either via driving hMSC stem cell therapy or direct targeting. Graphical abstract: Heparan sulfate proteoglycans as regulators of human mesenchymal stem cell neurogenesis. Traumatic brain injury (TBI) and genetic factors increase Alzheimer’s disease (AD) risk (yellow). Potential AD treatment targets (green) include human mesenchymal stem cells (hMSCs). Manipulating pathway and growth factor interactions with heparan sulfate proteoglycans (HSPGs) could regulate hMSC neurogenesis, potentially offering functional neural stem cell transplants as AD treatments

Translated text

Key words

Heparan sulfate proteoglycan,Alzheimer’s disease,Traumatic brain injury,Human mesenchymal stem cell,Neurogenesis,Amyloid beta

Bibtex

AI Read Science

AI Summary

AI Summary is the key point extracted automatically understanding the full text of the paper, including the background, methods, results, conclusions, icons and other key content, so that you can get the outline of the paper at a glance.

Example

Background

Key content

Introduction

Methods

Results

Related work

Fund

Key content

Pretraining has recently greatly promoted the development of natural language processing (NLP)
We show that M6 outperforms the baselines in multimodal downstream tasks, and the large M6 with 10 parameters can reach a better performance
We propose a method called M6 that is able to process information of multiple modalities and perform both single-modal and cross-modal understanding and generation
The model is scaled to large model with 10 billion parameters with sophisticated deployment, and the 10 -parameter M6-large is the largest pretrained model in Chinese
Experimental results show that our proposed M6 outperforms the baseline in a number of downstream tasks concerning both single modality and multiple modalities We will continue the pretraining of extremely large models by increasing data to explore the limit of its performance

Try using models to generate summary,it takes about 60s

Must-Reading Tree

Example

Generate MRT to find the research sequence of this paper